Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
OPKO Health's subsidiary, ModeX Therapeutics, has initiated a Phase 1 clinical trial evaluating MDX2301, a tetravalent bispecific antibody designed to neutralize all known SARS-CoV-2 variants, to prevent COVID-19. This first-in-human study focuses on safety, tolerability, and pharmacokinetics across different administration routes in healthy and hi…
AVITA Medical has secured a 10-year agreement with the U.S. government's BARDA valued at up to $25.5 million to provide rapid access to its RECELL technology for burn mass casualty incidents. The contract includes maintaining inventory and readiness to deploy up to 3,000 units nationwide, supporting national preparedness and emergency response capa…
Pacira BioSciences announced its participation in a virtual fireside chat at the 25th Annual Needham Virtual Healthcare Conference and disclosed inducement stock awards granted to new employees under its Inducement Plan, including stock options and restricted stock units with scheduled vesting. The company highlighted its commitment to innovative n…
Xos, Inc. announced its strategic entry into the U.S. defense sector by showcasing its mobile charging platform at TEVCON 2026. The company's grid-independent, rapidly deployable energy solutions address key military challenges such as grid dependency, slow infrastructure timelines, and high operational energy costs. With over 100 commercial deploy…
Kimco Realty, a leading US REIT specializing in grocery-anchored shopping centers and mixed-use properties, will report its Q1 2026 earnings before market open on April 30, 2026. The company invites investors to join a live webcast and conference call to discuss results and outlook. Kimco owns interests in 565 U.S. shopping centers totaling 100 mil…
Amarin Corporation highlights the pivotal role of icosapent ethyl (IPE) in addressing elevated triglycerides and residual cardiovascular risk, as presented at the ACC Scientific Sessions 2026. Supporting new analyses from the REDUCE-IT trial and updated 2026 ACC/AHA guidelines underscore the need for complementary therapies beyond statins. IPE demo…
National Bank Holdings Corporation (NYSE: NBHC) will release its first quarter 2026 financial results on April 21, 2026, followed by a management conference call on April 22 to discuss the results and company updates. The announcement outlines the bank's operating footprint and services across multiple states.
NewAmsterdam Pharma, a late-stage clinical biopharmaceutical company focused on developing oral, non-statin therapies for cardiovascular disease patients with elevated LDL cholesterol, will present at the upcoming Needham Virtual Healthcare Conference. The company's CFO and EVP of Investor Relations will participate in a virtual fireside chat to di…
Absci Corporation, a clinical-stage biopharmaceutical company specializing in AI-driven drug discovery, announced its participation in the 25th Annual Needham Virtual Healthcare Conference. The company will engage in a fireside chat highlighting its Integrated Drug Creation platform and promising pipeline assets like ABS-201, focused on hair regrow…
Healthcare Realty Trust Incorporated announced that it will report its first quarter 2026 earnings on April 30, 2026, after market close, followed by a conference call on May 1, 2026, to discuss the results and company operations. The company is the largest publicly traded owner, operator, and developer of medical outpatient buildings in the U.S.
Lifecore Biomedical, a Nasdaq-listed CDMO specializing in injectable pharmaceutical products, announced its participation at the 12th Annual American Biomanufacturing Summit in San Francisco on April 14-15, 2026. The company will present its process development and manufacturing services for injectable programs and engage with industry stakeholders…
FormFactor, Inc. will release its first quarter of fiscal 2026 financial results on April 29, 2026. The company invites the public to listen to a live webcast of its earnings conference call and provides details for preregistering for telephone access. FormFactor is a leading provider of test and measurement technologies for the semiconductor indus…
Sunrun Inc., a leading provider of home solar and battery storage solutions, announced it will report its first quarter 2026 earnings after market close on May 6, 2026, followed by a conference call at 1:30 p.m. Pacific Time. The company invites investors and analysts to join the call via their website or phone, with replay and transcript available…
Annexon, Inc., a biopharmaceutical company focused on targeted immunotherapies for neuroinflammatory diseases, announced its CEO will present at the upcoming Needham Virtual Healthcare Conference. The presentation will discuss Annexon's platform targeting classical complement-driven neuroinflammation and its potential to provide functional benefits…
SLR Investment Corp. will release its financial results for the first quarter ending March 31, 2026, on May 5, 2026, after market close, followed by a conference call and webcast on May 6. The company is a business development company focusing on leveraged loans to U.S. middle-market companies.
Kyntra Bio announced that it will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026. The CEO will discuss the company's progress in developing novel oncology and rare disease treatments, including ongoing clinical trials of their drugs roxadustat and FG-3246. A webcast and replay will be available for investors.
Cue Biopharma announced it will receive a $7.5 million preclinical milestone payment from Boehringer Ingelheim following the selection and approval of its first compound for lead optimization. This milestone validates the progress of Cue Biopharma's collaboration to develop innovative therapeutics for autoimmune and inflammatory diseases leveraging…
Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) announced that it will release its first quarter 2026 financial results after market close on April 28, 2026, followed by a conference call on April 29 to discuss performance and recent events. The company is a real estate investment trust specializing in commercial real estate debt investment…
Artiva Biotherapeutics, a clinical-stage biotech firm focused on cell therapies for autoimmune diseases and cancers, will participate in panel discussions and a fireside chat at the upcoming Needham Virtual Healthcare Conference, showcasing its lead AlloNK® program and pipeline advancement.
Tyson Foods, Inc. announced it will release its second quarter 2026 financial results on May 4, 2026, followed by a management conference call and webcast. Supplemental materials will be available prior to the market opening. The call will provide investors and analysts insights into the company's performance for the quarter.
Constellation Brands reported its financial results for the full fiscal year and fourth quarter of 2026, with a scheduled conference call featuring current and incoming CEOs. The company highlighted its position as a leading international beverage alcohol producer and reiterated its commitment to sustainability and growth across its brands.
3 E Network Technology Group Limited announced that it has regained compliance with Nasdaq's minimum bid price requirement, avoiding delisting. Following a period below the $1 per share threshold, the company's stock price rose above $1 for ten consecutive days, leading to the cancellation of a previously planned appeal. The company sees this compl…
Applied Digital Corporation reported fiscal Q3 2026 revenues of $126.6 million, a 139% increase year-over-year, driven by its HPC Hosting and Data Center Hosting businesses. The company broke ground on a major new 300 MW AI Factory campus, secured $2.15 billion in senior secured notes to fund data center development, and strengthened lease agreemen…
Nasdaq announced its trading volumes for March 2026 along with quarterly volumes, estimated revenue capture, number of listings, and index statistics for the first quarter ended March 31, 2026. The detailed data is available on Nasdaq's Investor Relations website.
RxSight, a U.S.-listed ophthalmic medical device company, announced that over 300,000 Light Adjustable Lens implants have been performed, marking a significant milestone. The company is presenting extensive scientific research on its innovative lens technology at the ASCRS 2026 meeting and is launching a new marketing program highlighting surgeon e…
